Harnessing generative AI on AWS to Accelerate Innovation at Johnson & Johnson | Amazon Web Services

Johnson & Johnson is advancing its mission to prevent, treat, and cure complex diseases by leveraging generative AI on AWS. Since setting a cloud migration goal in 2019, the company has now moved most of its workload to AWS. With AWS as a strategic cloud and gen AI partner, J&J has built a secure, high-performance environment that enables teams to experiment and innovate with speed and scale innovation across its global organization - from accelerating drug discovery to advancing personalized medicine.

Subscribe to AWS: https://go.aws/subscribe

Sign up for AWS: https://go.aws/signup
AWS free tier: https://go.aws/free
Explore more: https://go.aws/more
Contact AWS: https://go.aws/contact

Next steps:
Explore on AWS in Analyst Research: https://go.aws/reports
Discover, deploy, and manage software that runs on AWS: https://go.aws/marketplace
Join the AWS Partner Network: https://go.aws/partners
Learn more on how Amazon builds and operates software: https://go.aws/library

Do you have technical AWS questions?
Ask the community of experts on AWS re:Post: https://go.aws/3lPaoPb

Why AWS?
Amazon Web Services (AWS) is the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—use AWS to be more agile, lower costs, and innovate faster.

#AWS #AmazonWebServices #CloudComputing

Видео Harnessing generative AI on AWS to Accelerate Innovation at Johnson & Johnson | Amazon Web Services канала Amazon Web Services